First causally effective drug against Alzheimer's? : The FDA approves aducanumab

Nervenarzt. 2021 Sep 7. doi: 10.1007/s00115-021-01182-1. Online ahead of print.NO ABSTRACTPMID:34494135 | DOI:10.1007/s00115-021-01182-1

Source: Der Nervenarzt - September 8, 2021 Category: Neurology Authors: Klaus Hager Source Type: research